Moreover, another important hypothesis is that the free fatty acid receptor 4 (FFAR4), a G protein-coupled receptor for endogenous medium- or long-chain fatty acids that attenuates metabolic diseases and inflammation, may play a role. Here, FFAR4 is linked to metabolic disease.